» Articles » PMID: 6518293

Effect of Sodium Butyrate on Human Breast Carcinoma (MCF-7) Cellular Proliferation, Morphology, and CEA Production

Overview
Specialty Oncology
Date 1984 Jan 1
PMID 6518293
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Sodium butyrate is a potent inducer of leukemic cell differentiation. This agent also affects epithelial cell proliferation and gene expression. The present study demonstrates that sodium butyrate slows proliferation and induces morphologic changes in human MCF-7 breast carcinoma cells. The results also demonstrate that butyrate-treated MCF-7 cells have enhanced expression of carcinoembryonic antigen. These effects are related to butyrate concentration and duration of exposure. The present findings may provide a model for studying maturation of human breast cancer cells.

Citing Articles

Sodium Butyrate (NaB) and Sodium Propionate (NaP) Reduce Cyclin A2 Expression, Inducing Cell Cycle Arrest and Proliferation Inhibition of Different Breast Cancer Subtypes, Leading to Apoptosis.

Ibrahim J, El-Hakim S, Semaan J, Ghosn S, El Ayoubi H, Elnar A Biomedicines. 2024; 12(8).

PMID: 39200243 PMC: 11351769. DOI: 10.3390/biomedicines12081779.


Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells.

Jaye K, Alsherbiny M, Chang D, Li C, Bhuyan D Int J Mol Sci. 2023; 24(20).

PMID: 37894734 PMC: 10606851. DOI: 10.3390/ijms242015053.


Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy.

Jaye K, Chang D, Li C, Bhuyan D Int J Mol Sci. 2022; 23(16).

PMID: 36012771 PMC: 9409206. DOI: 10.3390/ijms23169490.


Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment.

Salimi V, Shahsavari Z, Safizadeh B, Hosseini A, Khademian N, Tavakoli-Yaraki M Lipids Health Dis. 2017; 16(1):208.

PMID: 29096636 PMC: 5669027. DOI: 10.1186/s12944-017-0593-4.


Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.

Knutson S, Raja E, Bomgarden R, Nlend M, Chen A, Kalyanasundaram R PLoS One. 2016; 11(6):e0157762.

PMID: 27336622 PMC: 4918962. DOI: 10.1371/journal.pone.0157762.


References
1.
Collins S, Ruscetti F, Gallagher R, Gallo R . Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978; 75(5):2458-62. PMC: 392573. DOI: 10.1073/pnas.75.5.2458. View

2.
Walker R . Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique. J Clin Pathol. 1980; 33(4):356-60. PMC: 1146078. DOI: 10.1136/jcp.33.4.356. View

3.
Shousha S, Lyssiotis T, Godfrey V, Scheuer P . Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator. Br Med J. 1979; 1(6166):777-9. PMC: 1598471. DOI: 10.1136/bmj.1.6166.777. View

4.
Dexter D, Crabtree G, Stoeckler J, Savarese T, Ghoda L, Parks Jr R . N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells. Cancer Res. 1981; 41(3):808-12. View

5.
Kim Y, Tsao D, Siddiqui B, WHITEHEAD J, ARNSTEIN P, Bennett J . Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer. 1980; 45(5 Suppl):1185-92. DOI: 10.1002/1097-0142(19800315)45:5+<1185::aid-cncr2820451324>3.0.co;2-w. View